Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier State | 2 | 2018 | 67 | 1.040 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 450 | 0.800 |
Why?
|
| Pruritus | 1 | 2020 | 63 | 0.660 |
Why?
|
| Wound Infection | 1 | 2018 | 32 | 0.570 |
Why?
|
| Cicatrix | 1 | 2018 | 64 | 0.560 |
Why?
|
| Dermatologic Agents | 1 | 2018 | 70 | 0.550 |
Why?
|
| Psoriasis | 1 | 2018 | 102 | 0.540 |
Why?
|
| Obesity, Abdominal | 1 | 2016 | 48 | 0.510 |
Why?
|
| Nasal Cavity | 1 | 2016 | 52 | 0.490 |
Why?
|
| Herpes Simplex | 1 | 2016 | 95 | 0.490 |
Why?
|
| Wound Healing | 1 | 2018 | 331 | 0.470 |
Why?
|
| Menstrual Cycle | 1 | 2016 | 133 | 0.470 |
Why?
|
| Burns | 1 | 2018 | 325 | 0.420 |
Why?
|
| Skin | 1 | 2018 | 752 | 0.410 |
Why?
|
| Adiposity | 1 | 2016 | 518 | 0.360 |
Why?
|
| Microbiota | 1 | 2018 | 762 | 0.330 |
Why?
|
| Taiwan | 5 | 2020 | 31 | 0.310 |
Why?
|
| Quality of Life | 1 | 2020 | 2892 | 0.290 |
Why?
|
| Occupational Exposure | 2 | 2016 | 341 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 2828 | 0.190 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 570 | 0.180 |
Why?
|
| Sepsis | 2 | 2016 | 617 | 0.170 |
Why?
|
| Adult | 8 | 2020 | 37929 | 0.160 |
Why?
|
| China | 1 | 2020 | 217 | 0.160 |
Why?
|
| Middle Aged | 9 | 2018 | 33479 | 0.160 |
Why?
|
| Nails | 1 | 2018 | 12 | 0.150 |
Why?
|
| Nose | 1 | 2018 | 67 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 106 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 5472 | 0.130 |
Why?
|
| Ceramics | 1 | 2016 | 22 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2018 | 7604 | 0.130 |
Why?
|
| Emergency Service, Hospital | 3 | 2016 | 2069 | 0.130 |
Why?
|
| Silicosis | 1 | 2016 | 27 | 0.130 |
Why?
|
| Nickel | 1 | 2016 | 62 | 0.130 |
Why?
|
| Office Visits | 1 | 2016 | 93 | 0.130 |
Why?
|
| Waist Circumference | 1 | 2016 | 143 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 549 | 0.120 |
Why?
|
| Interleukin-18 | 1 | 2016 | 236 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 266 | 0.120 |
Why?
|
| Forecasting | 1 | 2016 | 389 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2018 | 435 | 0.110 |
Why?
|
| Heart Rate | 1 | 2018 | 822 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 242 | 0.110 |
Why?
|
| Female | 10 | 2018 | 73304 | 0.110 |
Why?
|
| Humans | 12 | 2020 | 137585 | 0.100 |
Why?
|
| Disease Management | 1 | 2016 | 628 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 3284 | 0.100 |
Why?
|
| Male | 9 | 2018 | 67762 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2016 | 911 | 0.090 |
Why?
|
| Time Factors | 2 | 2018 | 6828 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2016 | 1317 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2734 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 1046 | 0.080 |
Why?
|
| Young Adult | 4 | 2018 | 13209 | 0.080 |
Why?
|
| Risk Factors | 3 | 2016 | 10388 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5778 | 0.070 |
Why?
|
| Prognosis | 3 | 2018 | 4030 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5131 | 0.050 |
Why?
|
| Biomarkers | 3 | 2016 | 4149 | 0.040 |
Why?
|
| Aged | 5 | 2018 | 23961 | 0.040 |
Why?
|
| United States | 1 | 2016 | 14841 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2016 | 15657 | 0.040 |
Why?
|
| Electroplating | 1 | 2016 | 1 | 0.030 |
Why?
|
| Chills | 1 | 2016 | 2 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2016 | 30 | 0.030 |
Why?
|
| Calcitonin | 1 | 2016 | 27 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 130 | 0.030 |
Why?
|
| Hypothermia | 1 | 2016 | 36 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 167 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 160 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 629 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1266 | 0.030 |
Why?
|
| Anemia | 1 | 2016 | 170 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 305 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 554 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 356 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 600 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7635 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 410 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1070 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1509 | 0.030 |
Why?
|
| Antioxidants | 1 | 2016 | 584 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1129 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 421 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2016 | 669 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1622 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 2074 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1357 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 2071 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 2804 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 2844 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 3295 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2757 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 1468 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5742 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 11074 | 0.010 |
Why?
|
| Neoplasms | 1 | 2016 | 2671 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 21513 | 0.010 |
Why?
|
| Child | 1 | 2016 | 21935 | 0.010 |
Why?
|